Exploring Immunotherapy for Carcinoid and Pancreatic Neuroendocrine Tumors – Newswise (press release)
|
Exploring Immunotherapy for Carcinoid and Pancreatic Neuroendocrine Tumors
Newswise (press release) Newswise — New Brunswick, N.J. – September 5, 2017 – A clinical trial testing the immunotherapy drug pembrolizumab shows the drug to be well tolerated among patients who have carcinoid or pancreatic neuroendocrine tumors. Janice M. Mehnert, MD, … |
|
Exploring Immunotherapy for Carcinoid and Pancreatic Neuroendocrine Tumors
Newswise (press release) Newswise — New Brunswick, N.J. – September 5, 2017 – A clinical trial testing the immunotherapy drug pembrolizumab shows the drug to be well tolerated among patients who have carcinoid or pancreatic neuroendocrine tumors. Janice M. Mehnert, MD, … |
HuffPost |
Eterna Citizen Science Game Turns Its Attention To CRISPR
HuffPost The latest version sees players tasked with designing a CRISPR-controlling molecule. The design of the challenge is to develop an RNA molecule that’s capable of acting as an on/off switch for CRISPR. The resulting molecules will then be tested by … |
Washington University School of Medicine in St. Louis |
Zika virus kills brain cancer stem cells
Washington University School of Medicine in St. Louis Brain cancer stem cells (left) are killed by Zika virus infection (image at right shows cells after Zika treatment). A new study shows that the virus, known for killing cells in the brains of developing fetuses, could be redirected to destroy the kind … Zika kills brain cancer cells, may find use as therapyThe San Diego Union-Tribune Zika virus could be used to treat brain cancer, new study suggestsResearchGate (blog) Could the Zika Virus Help Battle a Deadly Brain Cancer?U.S. News & World Report EurekAlert (press release) –Genetic Engineering & Biotechnology News (blog) –Alphr all 12 news articles » |
|
FDA approves first gene therapy in the United States
Pharmacy Today, American Pharmacists Association, pharmacist.com FDA has approved the first gene therapy in the United States, tisagenlecleucel (Kymriah—Novartis), ushering in a new approach to treatment of cancer and other serious and life-threatening diseases, said the agency in a recent news release. |
|
FDA approves first gene therapy in the United States
Pharmacy Today, American Pharmacists Association, pharmacist.com FDA has approved the first gene therapy in the United States, tisagenlecleucel (Kymriah—Novartis), ushering in a new approach to treatment of cancer and other serious and life-threatening diseases, said the agency in a recent news release. |
Medical Xpress |
Zika virus kills brain cancer stem cells; could potentially be used to treat deadly disease
Medical Xpress Brain cancer stem cells (left) are killed by Zika virus infection (image at right shows cells after Zika treatment). A new study shows that the virus, known for killing cells in the brains of developing fetuses, could be redirected to …more. While … Zika kills brain cancer cells, may find use as therapyThe San Diego Union-Tribune Zika virus used to treat aggressive brain cancerBBC News Could the Zika virus be harnessed to treat brain cancer?Medical News Today Philly.com –ResearchGate (blog) –Alphr all 16 news articles » |
|
Gilead Sciences Couldn’t Have Timed its Splash Into CAR–T Better
Motley Fool The FDA approved the world’s first CAR-T therapy on Wednesday, one month ahead of schedule, and only days after Gilead Sciences announced it’s buying CAR-T powerhouse Kite Pharma in a deal valued at $11.9 billion. …. and reengineer them in a certain … |